Drew M. Diaz named Chief Executive Officer of Bone Solutions Inc. (BSI)

Top Quote Bone Solutions Inc. (BSI) has named Drew Diaz, a twenty seven year professional in the health care industry and current company President, as the new Chief Executive Officer and President. End Quote
  • Dallas, TX (1888PressRelease) January 30, 2015 - Mr. Diaz has worked in the health care field for over twenty seven years. Mr. Diaz served 5 years as the co-founder and Chief Executive Officer of Heart Test Laboratories Inc., a US based cardiology device company. Prior to Heart Test Laboratories, Mr. Diaz was the Senior Vice President of Global Sales for Criticare Systems, Inc., a US manufacturer of anesthesia, cardiac and patient monitoring equipment. Mr. Diaz and has held positions with various Fortune 500 companies, including IBM, Pfizer, and DeRoyal Industries throughout his career.

    His knowledge in opening new markets and driving revenue via distribution networks and direct organizations in a global economy has been critical in the growth of these companies. Well versed in international trade and management, Mr. Diaz has managed offices in Brazil, China, Germany, India, and the United States. As the Managing Director and President of Medical Logistics GMbH, a medical device company in Bad Homburg Germany. He is a graduate of Texas A&M University and has attended Harvard University Business School for Executive Training.

    For the past 14 months Mr. Diaz served as the President of Bone Solutions, and will oversee this year's launch of their innovative adhesive bone void filler, OsteoCrete, into the global market. Manufacturing has been contracted with the Wisconsin based company, Preservation Solutions (PreservationSolutions.com).

    About Bone Solutions, Inc
    Bone Solutions Inc. ('BSI') (www.bonesolutionsinc.com) intends to establish its magnesium based platform as the 'one stop bone, tendon and ligament injectable, biodegradable adhesive technology' for surgeries in hospitals, clinics and other private surgical centers within the orthopedic industry. The Company believes it is revolutionizing a new solution for orthopedic surgeons for human uses with a magnesium based platform that may attach for the first time in orthopedic medical history bone to bone, as well as ligaments and tendons to bone.

  • FB Icon Twitter Icon In-Icon
Contact Information